|
|
|
|
|
|
|
|
|
|
|
|
|
13.02.26 - 13:03
|
Insmed To Present at March 2026 Investor Conferences (PR Newswire)
|
|
|
BRIDGEWATER, N.J., Feb. 13, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29.01.26 - 13:03
|
Definium Therapeutics Appoints Roger Adsett to Board of Directors (Business Wire)
|
|
|
Seasoned biopharmaceutical leader brings deep commercial, operational, and launch expertise to support Definium's next phase of growthNEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.) today announced the appointment of Roger Adsett to its Board of Directors effective immediately.
“We are thrilled to welcome Roger to our Board of Directors,” said Rob Barrow, Chief Executive Officer of Definium Therapeutics. “Roger is a respected and proven leader with deep experience building high-performing commercial organizations and guiding transformational therapies from launch to meaningful market impact. At Insmed, he's led the development of world-class commercial and operational capabilities supporting the company on its mission to transform the lives of patients facing serious diseases. His ability to translate innovative science into disciplined, large-scale commercial execution will be especially valuable as we approach three anticipated Phase 3 readouts in 2...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
